Company / CapEx per Share
Astria Therapeutics, Inc. CapEx per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.01
FY2024
5-year range
$0.00 / $0.01
FY2020-FY2024
Trend
+597.3%
vs FY2023
Sector context
#138 of 192
Health Care
What the data says
CapEx per Share changed +597% YoY in FY2024, a notable deviation from the 8-year average annual change of +152%.
Based on SEC 10-K filings.
0.01 in FY2024 with a 5-year CAGR of +36.1%.
Declined from $0.01 to $0.01 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +35.0%
- 5-Year CAGR
- +36.1%
- 10-Year CAGR
- -
Sector benchmark
#138 of 192 in Health CareTop 72% of 192This company $0.01 Sector average $3.54
▼
-99.8% below sector average
Key checks
Key Insights
- In FY2024, capex per share increased 597.3% year-over-year.
- Ranks #138 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2015.
- Lowest capex per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 5.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.01 | +597.3% |
| FY2023 | $0.00 | -86.7% |
| FY2022 | $0.01 | +164.5% |
| FY2021 | $0.00 | -78.2% |
| FY2020 | $0.01 | +770.9% |
| FY2019 | $0.00 | - |
| FY2018 | - | - |
| FY2017 | $0.03 | -7.0% |
| FY2016 | $0.03 | -46.0% |
| FY2015 | $0.05 | -90.3% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026